New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

ARKGvsPSCHETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.05%
Full ARKG fund page
VS
ETF 2
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
-0.3%
Full PSCH fund page

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PSCH's top sector exposures are Health Care  ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.29% for PSCH. ARKG is down -5.11% year-to-date (YTD) with -$10M in YTD flows. PSCH performs worse with -9.62% YTD performance, and -$14M in YTD flows. Run a side-by-side ETF comparison of ARKG and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs PSCH performance and flow charts

Performance

-6.0-4.0-2.00.02.04.06.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

-60 M-40 M-20 M0 M20 M40 M60 M80 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
PSCH
-3.62%-6.23%
-10.23%-13.21%
-5.11%-9.62%
+23.23%-2.92%
-2.84%-5.60%
-70.08%-37.57%
Flows
ARKG
PSCH
-$50M-$12M
-$85M-$15M
-$10M-$14M
-$210M-$33M
-$627M-$168M
-$2.79B-$230M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
PSCH
+39.15%+19.05%
+44.62%+23.11%
+42.26%+21.50%
+45.19%+22.79%
Max drawdown
ARKG
PSCH
-19.50%-13.97%
-23.94%-13.97%
-51.98%-23.50%
-80.33%-47.23%
Max drawdown duration
ARKG
PSCH
48d81d
77d81d
966d449d
1822d1720d
Trading data

Create an account to view trading data

Join for free
ARKG
PSCH
Last sale
3/13/2026 at 1:30 PM
$26.36
$39.79
Previous close
03/12/2026
$26.17
$39.81
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
PSCH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
ARKG
PSCH
Last price
$26.36
$39.79
1D performance
+0.73%
-0.05%
AuM$1.11 B$120.34 M
E/R0.75%0.29%
Characteristics
ARKG
PSCH
Management strategyActivePassive
ProviderArk InvestmentInvesco
Benchmark-S&P SmallCap 600 Capped Health Care Index
N° of holdings3071
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019April 7, 2010
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
73.95%
Switzerland
8.01%
Other
18.04%
PSCH
USA
95.98%
Other
4.02%

Sectors

ARKG
Health Care
80.46%
Other
19.54%
PSCH
Health Care
91.17%
Other
8.83%
Advertisement

Diversification

ARKG

Total weight of top 15 holdings out of 15

63.79%
PSCH

Total weight of top 15 holdings out of 15

43.5%

Top 15 holdings

Data as of January 31, 2026
ARKG
CRISPR THERAPEUTICS
8.01%
PERSONALIS INC
6.15%
GUARDANT HEALTH INC
6.00%
10X GENOMICS INC
5.23%
BEAM THERAPEUTICS
4.81%
ILLUMINA
4.53%
NATERA
4.31%
RECURSION PHARMACEUTICALS
4.01%
CAREDX INC/D
3.44%
VERACYTE INC/D
3.29%
ADAPTIVE BIOTECHNOLOGIES
3.13%
INTELLIA THERAPEUTICS INC
3.10%
ABSCI
2.83%
IONIS PHARMACEUTICALS INC
2.62%
SCHRODINGER
2.33%
PSCH
ARROWHEAD PHARMACEUTICALS INC
4.98%
KRYSTAL BIOTECH INC
3.88%
GLAUKOS
3.85%
PTC THERAPEUTI/D
3.30%
ALKERMES
2.95%
RADNET
2.78%
MERIT MEDICAL SYSTEMS
2.64%
PROTAGONIST THERAPEUTICS INC
2.61%
TRANSMEDICS GROUP
2.57%
TELEFLEX
2.48%
US10950A1060
2.46%
CORCEPT THERAPEUTICS
2.31%
US45579U1097
2.26%
TG THERAPEUTICS
2.25%
ADMA BIOLOGICS INC
2.18%
Frequently asked questions about ARKG and PSCH

How have the ARKG and PSCH ETFs performed in 2026?

As of March 11, 2026, ARKG is down -5.11% year-to-date (YTD), while PSCH has lost -9.62%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or PSCH?

Year-to-date, the ARKG ETF saw -$10M in flows, compared to -$14M for PSCH.

Which ETF is more volatile: ARKG or PSCH?

Over the past year, ARKG had a volatility of 44.62%, while PSCH experienced 23.11%.

Which ETF is bigger: ARKG or PSCH?

As of March 11, 2026, ARKG holds $1.11 B in assets under management (AUM), while PSCH manages $120.34 M.

What sectors do the ARKG and PSCH ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.

What are the top holdings of the ARKG ETF and PSCH ETF?

ARKG top holdings include CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC. PSCH holds in its top three: ARROWHEAD PHARMACEUTICALS INC, KRYSTAL BIOTECH INC and GLAUKOS.

Which ETF is more diversified: ARKG or PSCH?

ARKG holds 30 securities with 63.79% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 43.5%.

Advertisement
Latest news about ARKG & PSCH
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up